AstraZeneca Plc (NASDAQ: AZN) has reported Q1 FY23 core EPS of $1.92, up 1% Y/Y (+6% on constant currency), better than the consensus of $1.07.
The company clocked Q1 sales of $10.88 billion, -4% (flat CC), beating the consensus of $10.75 billion.
Suncor Energy Inc (NYSE:SU) announced the acquisition of Canadian operations of TotalEnergies SE (NYSE:TTE) for CA$5.5 billion. The deal also includes probable…